As of 2024-12-11, the Relative Valuation of Syros Pharmaceuticals Inc (SYRS) is (43.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Syros Pharmaceuticals Inc based on Relative Valuation is -17850.3%.
The range of the Relative Valuation is (18.59) - (67.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 18.4x | 11.8x |
| Forward P/E multiples | 5.1x - 18.9x | 12.0x |
| Fair Price | (18.59) - (67.08) | (43.29) |
| Upside | -7723.3% - -27603.7% | -17850.3% |
| Date | P/E |
| 2024-11-29 | -0.07 |
| 2024-11-27 | -0.07 |
| 2024-11-26 | -0.07 |
| 2024-11-25 | -0.07 |
| 2024-11-22 | -0.08 |
| 2024-11-21 | -0.07 |
| 2024-11-20 | -0.08 |
| 2024-11-19 | -0.08 |
| 2024-11-18 | -0.05 |
| 2024-11-15 | -0.07 |
| 2024-11-14 | -0.08 |
| 2024-11-13 | -0.10 |
| 2024-11-12 | -0.75 |
| 2024-11-11 | -0.89 |
| 2024-11-08 | -0.72 |
| 2024-11-07 | -0.70 |
| 2024-11-06 | -0.67 |
| 2024-11-05 | -0.69 |
| 2024-11-04 | -0.67 |
| 2024-11-01 | -0.62 |
| 2024-10-31 | -0.69 |
| 2024-10-30 | -0.69 |
| 2024-10-29 | -0.69 |
| 2024-10-28 | -0.58 |
| 2024-10-25 | -0.55 |
| 2024-10-24 | -0.57 |
| 2024-10-23 | -0.62 |
| 2024-10-22 | -0.68 |
| 2024-10-21 | -0.61 |
| 2024-10-18 | -0.54 |
| 2024-10-17 | -0.53 |
| 2024-10-16 | -0.52 |
| 2024-10-15 | -0.55 |
| 2024-10-14 | -0.54 |
| 2024-10-11 | -0.53 |
| 2024-10-10 | -0.53 |
| 2024-10-09 | -0.54 |
| 2024-10-08 | -0.55 |
| 2024-10-07 | -0.53 |
| 2024-10-04 | -0.54 |
| 2024-10-03 | -0.53 |
| 2024-10-02 | -0.53 |
| 2024-10-01 | -0.52 |
| 2024-09-30 | -0.59 |
| 2024-09-27 | -0.55 |
| 2024-09-26 | -0.54 |
| 2024-09-25 | -0.53 |
| 2024-09-24 | -0.53 |
| 2024-09-23 | -0.52 |
| 2024-09-20 | -0.53 |